tetano
Editor, Senior Moderator
Hum Vaccin Immunother
. 2024 Dec 31;20(1):2349319.
doi: 10.1080/21645515.2024.2349319. Epub 2024 May 16. Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale
Francesco Paolo Bianchi[SUP] 1 [/SUP], Maurizio Polignano[SUP] 2 [/SUP], Nicola Carella[SUP] 2 [/SUP], Ornella Rotolo[SUP] 2 [/SUP], Margherita Curlo[SUP] 2 [/SUP], Mauro Mastronardi[SUP] 2 [/SUP]
Affiliations
Individuals with Inflammatory Bowel Disease (IBD) are more susceptible to experiencing severe complications of COVID-19 if infected. Nevertheless, sub-optimal immunization rates have been reported among these patients. Our study aims to assess COVID-19 VH among a global population of patients with IBD and to investigate the role of healthcare professionals, particularly gastroenterologists, in promoting immunization. Twenty-six studies were systematically selected from scientific articles in the MEDLINE/PubMed, WoK, and Scopus databases from January 1, 2020, to September 15, 2023. The pooled prevalence of COVID-19 VH was 27.2% (95%CI = 20.6-34.2%). A significant relationship was evidenced between COVID-19 vaccine compliance and receiving advice from gastroenterologists or healthcare providers (OR = 2.77; 95%CI = 1.79-4.30). By leveraging their knowledge of IBD, familiarity with patient histories, and trusted patient-doctor relationships, gastroenterologists are pivotal in promoting vaccination. This patient-centered care is crucial in increasing vaccine acceptance among individuals with IBD, contributing to better public health outcomes.
Keywords: Crohn’s disease; SARS-CoV-2; biological drugs; immunization rates; immunosuppressive therapy; ulcerative colitis; vaccine compliance; vaccine hesitancy.
. 2024 Dec 31;20(1):2349319.
doi: 10.1080/21645515.2024.2349319. Epub 2024 May 16. Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale
Francesco Paolo Bianchi[SUP] 1 [/SUP], Maurizio Polignano[SUP] 2 [/SUP], Nicola Carella[SUP] 2 [/SUP], Ornella Rotolo[SUP] 2 [/SUP], Margherita Curlo[SUP] 2 [/SUP], Mauro Mastronardi[SUP] 2 [/SUP]
Affiliations
- PMID: 38755111
- DOI: 10.1080/21645515.2024.2349319
Individuals with Inflammatory Bowel Disease (IBD) are more susceptible to experiencing severe complications of COVID-19 if infected. Nevertheless, sub-optimal immunization rates have been reported among these patients. Our study aims to assess COVID-19 VH among a global population of patients with IBD and to investigate the role of healthcare professionals, particularly gastroenterologists, in promoting immunization. Twenty-six studies were systematically selected from scientific articles in the MEDLINE/PubMed, WoK, and Scopus databases from January 1, 2020, to September 15, 2023. The pooled prevalence of COVID-19 VH was 27.2% (95%CI = 20.6-34.2%). A significant relationship was evidenced between COVID-19 vaccine compliance and receiving advice from gastroenterologists or healthcare providers (OR = 2.77; 95%CI = 1.79-4.30). By leveraging their knowledge of IBD, familiarity with patient histories, and trusted patient-doctor relationships, gastroenterologists are pivotal in promoting vaccination. This patient-centered care is crucial in increasing vaccine acceptance among individuals with IBD, contributing to better public health outcomes.
Keywords: Crohn’s disease; SARS-CoV-2; biological drugs; immunization rates; immunosuppressive therapy; ulcerative colitis; vaccine compliance; vaccine hesitancy.